Inactive Instrument

PCAS Share Price

PCA

FR0000053514

PCAS specializes in developing, manufacturing, and marketing fine and specialty chemicals. Sales are distributed by family of products as follows: - synthesized pharmaceutical products (63.5%); - fine chemicals (36.5%): technical fluids and additives for the lubricant industry, chemical additive synthesis. The group also offers photochemical and new technology products (photosensitive materials, photo-initiators, and polymers for photography, reprography, and micro-electronics). At the end of 2022, the group had 7 production sites located in France (5), Canada and Finland. France accounts for 76% of net sales.

Employees

1,178

Sector

Pharmaceuticals

More about the company

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

09/24/09	Orapi: takeover bid reopens on February 12
02/24/02	Orapi: 3.15 million shares tendered to the takeover bid
22/23/22	Orapi: takeover bid opens on December 27
18/23/18	PCAS: 200 ME capital increase
03/23/03	PCAS: OPAS to start this Friday
24/23/24	PCAS Announces the Consolidated Net Sales Results for the Month of September 30, 2023	CI
16/23/16	Progyny, Inc. : Want to have a baby?
07/23/07	PCAS: Seqens launches minority share offer
06/23/06	PCAS SA Reports Earnings Results for the Half Year Ended June 30, 2023	CI
27/23/27	PCAS SA Reports Consolidated Sales Results for the Period Ended June 30, 2023	CI
01/23/01	DIC Corporation completed the acquisition of PCAS Canada Inc. from PCAS SA.	CI
25/23/25	PCAS: sale of Canadian subsidiary confirmed
25/23/25	PCAS to Divest Canadian Arm to Japan's DIC	MT

24/23/24	PCAS: Net Sales as of September 30, 2023	GL
06/23/06	PCAS: RESULTS AS OF JUNE 30, 2023	GL
27/23/27	Pcas: Net sales as of June 30, 2023	GL
25/23/25	PCAS to sell its Canadian subsidiary, PCAS Canada Inc., to DIC Corporation	GL
02/23/02	PCAS enters into exclusive negotiations with DIC Corporation following receipt of an offer for the acquisition of its Canadian subsidiary, PCAS Canada Inc.	GL

09/24/09	Orapi : l'OPA réouvre le 12 février
02/24/02	Orapi : 3,15 millions d'actions apportées à l'OPA
05/24/05	Progyny, Inc.: ¿Quieres tener un bebé?
22/23/22	Orapi : l'OPA démarre le 27 décembre
18/23/18	PCAS : augmentation de capital de 200 ME

Manager	Title	Age	Since
Gildas Barreyre CEO	Chief Executive Officer	43	03/05/2025
Eric Moissenot DFI	Director of Finance/CFO	-	-
Gérard Guillamot CTO	Chief Tech/Sci/R&D Officer	-	01/03/1999

Director	Title	Age	Since
Jacqueline Lecourtier BRD	Director/Board Member	74	01/03/2014
Janine Cossy BRD	Director/Board Member	-	-

PCAS Share Price

Stocks

PCA

FR0000053514

Pharmaceuticals

Latest news : PCAS

Press Releases: PCAS

News in other languages: PCAS

Managers and Directors: PCAS

Other Pharmaceuticals

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PCAS	-.--%	-.--%	-	-	12Cr
ELI LILLY AND COMPANY	-2.25%	-0.47%	+68.30%	+115.90%	1,05200Cr
JOHNSON & JOHNSON	-0.66%	+0.43%	+47.39%	+50.54%	63TCr
ABBVIE INC.	-0.54%	+1.39%	+20.69%	+63.99%	44TCr
ROCHE HOLDING AG	-1.99%	-3.32%	+38.71%	+35.41%	35TCr
NOVARTIS AG	-1.05%	-2.81%	+23.07%	+35.70%	29TCr
ASTRAZENECA PLC	-2.12%	-3.67%	-1.14%	+5.37%	24TCr
AMGEN INC.	-0.63%	+1.04%	+40.05%	+56.09%	22TCr
NOVO NORDISK A/S	-1.19%	-3.41%	-9.57%	-52.71%	20TCr
GILEAD SCIENCES, INC.	+0.16%	+3.87%	+16.89%	+73.73%	17TCr
Average	-1.03%	+0.43%	+27.15%	+42.67%	39.95TCr
Weighted average by Cap.	-1.36%	+0.32%	+39.09%	+61.29%